Search - tctmd.com

Displaying 361 - 380 of 1077

Sort: Relevancy | Date

REAL PTX: Head-to-Head DCB, DES Data in PAD Show Trend Favoring Stenting at 36 Months

News Daily News

REAL PTX: Head-to-Head DCB, DES Data in PAD Show Trend Favoring Stenting at 36 Months

February 11, 2018

MIMICS-2 at 1 Year: 3-D Stent Meets Safety and Effectiveness Goals

News Conference News ISET 2018

MIMICS-2 at 1 Year: 3-D Stent Meets Safety and Effectiveness Goals

February 08, 2018

Noninvasive Testing of CLI: Many Ways to Draw Up a ‘Roadmap’

News Conference News ISET 2018

Noninvasive Testing of CLI: Many Ways to Draw Up a ‘Roadmap’

February 05, 2018

Sodium Fluoride Imaging in AAAs Provides a Picture of Future Risk

News Daily News

Sodium Fluoride Imaging in AAAs Provides a Picture of Future Risk

January 30, 2018

COMPASS Analysis Explores Impact of Low-Dose Rivaroxaban Plus Aspirin on Stroke

News Conference News ISC 2018

COMPASS Analysis Explores Impact of Low-Dose Rivaroxaban Plus Aspirin on Stroke

January 25, 2018

Cardiovascular Disease and Risk Factors Increasing Among Patients Undergoing Noncardiac Surgery

News Daily News

Cardiovascular Disease and Risk Factors Increasing Among Patients Undergoing Noncardiac Surgery

Yael L. Maxwell

January 09, 2018

Burden of Readmission High in PAD Patients Following Revascularization

News Daily News

Burden of Readmission High in PAD Patients Following Revascularization

December 04, 2017

TCTMD’s Top 10 Most Popular Stories for November 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2017

November 29, 2017

Diabetes Drugs Show Benefit in PAD, but Only Mixed Results in Primary Prevention of CV Events

News Conference News AHA 2017

Diabetes Drugs Show Benefit in PAD, but Only Mixed Results in Primary Prevention of CV Events

Michael O'Riordan

November 17, 2017

Low-Dose Rivaroxaban Plus Aspirin Lowers Some Costs in COMPASS, but Full Economic Impact Unclear

News Conference News AHA 2017

Low-Dose Rivaroxaban Plus Aspirin Lowers Some Costs in COMPASS, but Full Economic Impact Unclear

November 14, 2017

Two FOURIER Subgroup Analyses Show Added Benefit of Evolocumab in Those With PAD, Prior MI

News Conference News AHA 2017

Two FOURIER Subgroup Analyses Show Added Benefit of Evolocumab in Those With PAD, Prior MI

Yael L. Maxwell

November 13, 2017

Positionable Shields Slash Radiation Exposure to Cath Lab Staff by Two-Thirds

News Daily News

Positionable Shields Slash Radiation Exposure to Cath Lab Staff by Two-Thirds

November 08, 2017

RECAP: In the Cath Lab, a Lead-free Pad Placed on the Patient Cuts Operator Radiation Exposure

News Conference News TCT 2017

RECAP: In the Cath Lab, a Lead-free Pad Placed on the Patient Cuts Operator Radiation Exposure

November 01, 2017

Lower Limb Revascularizations Increasing in PAD Patients on Dialysis

News Daily News

Lower Limb Revascularizations Increasing in PAD Patients on Dialysis

October 18, 2017

Same-Day Discharge After PAD Procedures Safe in Elderly Patients

News Daily News

Same-Day Discharge After PAD Procedures Safe in Elderly Patients

October 09, 2017

TCTMD’s Top 10 Most Popular Stories for September 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for September 2017

September 30, 2017

News Industry News

Eurocor announces the presentation of the 12 months data of the Freeway Stent Study at CIRSE in Copenhagen

September 19, 2017

Low-Dose Paclitaxel DCB Shows Long-term Durability in Treating PAD

News Conference News VIVA 2017

Low-Dose Paclitaxel DCB Shows Long-term Durability in Treating PAD

September 18, 2017

Mobile Health Technologies May Boost Diagnosis, Care for Patients With Structural Heart Disease

News Daily News

Mobile Health Technologies May Boost Diagnosis, Care for Patients With Structural Heart Disease

Yael L. Maxwell

September 15, 2017

COMPASS: All Signs Point to Big Impact in CAD and PAD, Experts Predict

News Features

COMPASS: All Signs Point to Big Impact in CAD and PAD, Experts Predict

September 15, 2017

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.